ERBB2 and breast cancer: Our results based on TCGA transcriptome data revealed that the ImmuneScore, StromalScore and ESTIMATEScore have a direct relationship with OS in patients with HER2+ BC, thus suggesting that TME-associated factors may potentially be used to estimate prognosis (30, 31).